CION Ameerpet
CT answers a different question from the scans that came before it. Not what is this mass but how far does disease extend — which is what determines whether surgery comes first, or chemotherapy does.
Women frequently ask why a scan for an ovarian problem includes the chest. The answer is that CT is not being used to look at the ovary — it is being used to stage the disease, and staging means establishing exactly how far it has reached.
Ovarian cancer spreads primarily across the peritoneal surfaces within the abdomen, but it can reach above the diaphragm — as deposits on the diaphragm itself, as enlarged nodes in the chest, or as fluid around the lung. Whether disease has crossed that boundary changes the stage, and the stage changes the treatment. A scan that stopped at the diaphragm would leave that question open.
This is also why CT is a poor choice for the earlier question of what is this ovarian mass. It does not read tissue types the way MRI does, and it does not show the fine internal detail of a cyst the way a transvaginal ultrasound does. Each scan has its job. CT's job is the map, not the identification.
The question is how far disease extends, not what the ovarian mass is made of.
Deposits on the diaphragm, chest nodes or pleural fluid all change the stage.
That is ultrasound's job first and MRI's second. CT does not read tissue types well.
The single most influential thing CT does is help decide whether surgery should come first. In advanced ovarian cancer, outcomes are strongly linked to whether all visible disease can be removed — complete cytoreduction. Where CT suggests that is achievable, primary surgery followed by chemotherapy is usually preferred. Where it suggests disease is too extensive for complete removal at the outset, chemotherapy is given first to shrink it, with surgery following. Neither route is a lesser option; the evidence supports each in its own circumstances. The CT is largely what decides which one you are on. Source: NCCN Ovarian Cancer guidelines.
Each of these appears in a staging CT report, and each feeds into the stage and the surgical plan.
| Site | What is assessed | Why it matters |
|---|---|---|
| The ovarian mass itself | Size, whether one or both ovaries, solid components. | Confirms the primary, though ultrasound and MRI characterise it better. |
| Omentum | Thickening or a solid "cake" of tumour over the bowel. | A very common site of spread and a key surgical consideration. |
| Peritoneal surfaces | Nodules and thickening across the abdominal lining. | Defines the extent of peritoneal disease, which drives the surgical plan. |
| Liver and spleen surfaces | Deposits on the surface versus within the organ. | Surface deposits are removable; disease inside the liver is a different stage. |
| Lymph nodes | Size and location in the pelvis, abdomen and chest. | Enlarged nodes raise the stage and influence how extensive surgery must be. |
| Ascites | Volume and distribution of free fluid. | Large volume suggests widespread peritoneal disease. See ascites. |
| Bowel and mesentery | Involvement of bowel loops or the mesenteric root. | Extensive mesenteric involvement can make complete removal unachievable. |
| Chest | Pleural fluid, lung nodules, nodes above the diaphragm. | Disease above the diaphragm changes the stage. This is why the chest is included. |
*CT cannot detect microscopic disease. This is precisely why ovarian cancer is staged surgically — samples taken during the operation frequently find deposits no scan could show.
CT is quick and straightforward. The main considerations are the contrast and the radiation.
You lie on a table that passes through a ring-shaped scanner — open at both ends rather than a tunnel, so it is much less enclosed than MRI and rarely a problem for claustrophobia. The scan itself takes only minutes, and you will be asked to hold your breath briefly for some sequences.
The whole appointment usually takes under half an hour including preparation. You may be asked not to eat for a few hours beforehand, and in some protocols to drink an oral contrast solution to outline the bowel.
A contrast agent is injected through a cannula in the arm to make blood vessels and tissues clearly visible. Many people notice a warm flush spreading through the body and a metallic taste as it goes in — both are expected and pass within a minute.
It is iodinated contrast, different from the gadolinium used in MRI. Tell the department if you have had a reaction to contrast previously, if you have asthma, or if you have kidney problems, since a kidney function test is usually checked beforehand.
CT does involve ionising radiation, and a chest-abdomen-pelvis scan delivers considerably more than a plain X-ray. That is a genuine consideration, and it is why CT is not used casually or repeated without reason.
In the context of staging a suspected or confirmed cancer, the information it provides substantially outweighs the radiation risk. Where the question is characterising a mass rather than staging disease, MRI is preferred partly because it avoids radiation entirely — particularly relevant in younger women.
CT is generally avoided during pregnancy because of the radiation exposure to the fetus. Where cross-sectional imaging is needed, MRI without contrast is used instead, and it is considered safe.
If there is any possibility you could be pregnant, say so before the scan. A pregnancy test may be done first, and this is routine rather than an obstacle.
If you take metformin, mention it. Depending on your kidney function and local protocol, you may be advised to stop it briefly around the time of a contrast scan.
This is a standard precaution rather than a sign of concern, and the department will tell you exactly what to do. Do not stop any medication without being advised to.
It cannot detect microscopic disease, which is fundamental to understanding ovarian cancer staging. Deposits too small to appear on any scan are frequently found in samples taken during surgery — and they change the stage. This is exactly why staging is surgical rather than radiological.
It also cannot give a tissue diagnosis, and it characterises small ovarian masses poorly compared with ultrasound and MRI. A CT that shows no obvious spread is genuinely useful information, but it is not the same as confirming early disease.
The CT report largely explains the treatment plan, so these questions tend to be productive.
Or chemotherapy first? Ask what the imaging indicated about whether complete removal looks achievable.
Pleural fluid or chest nodes change the stage, which is why the chest was scanned.
A very common site of spread and a key part of what surgery would need to address.
The surgery-first versus chemotherapy-first decision should be a multidisciplinary one.
Where resectability is genuinely uncertain, looking directly is sometimes better than more imaging.
Usually after chemotherapy to assess response. Ask when and what it will be looking for.
A CT showing extensive disease is not the same as untreatable disease. Chemotherapy first, then interval surgery, is a well-established route with good evidence behind it.
Its main job is establishing whether surgery first or chemotherapy first gives the better result. That is a genuine decision, and it is worth understanding why yours went the way it did.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Bring the report — it usually explains why the treatment plan is what it is.
A staging CT report is a dense list of anatomical sites, and it is usually the document that determines the shape of treatment — yet it is frequently summarised in a sentence. Women are told whether surgery or chemotherapy comes first without being told what in the scan led to that.
Your first consultation at CION is free and runs to about 45 minutes. Bring the CT report. Much of the useful work is going through what it actually found, why the plan follows from it, and — where chemotherapy is going first — being clear that this is a well-evidenced route rather than a sign that surgery has been ruled out.
We should be clear about who does what. Chemotherapy and maintenance therapy, including neoadjuvant treatment before interval surgery, are delivered in-house at CION across 35+ centres in Telangana and Andhra Pradesh, as are genetic counselling and BRCA and HRD testing. Debulking and staging surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. Every case that raises a question goes to a tumour board.
Free and unhurried. Long enough to go through what the CT found and why the plan follows from it.
Where complete removal is not achievable upfront, treating first then operating is well-evidenced.
The surgery-first versus chemotherapy-first decision is made multidisciplinarily, not by one clinician.
Including neoadjuvant treatment, delivered across 35+ centres near where you live.
Having ultrasound, then MRI, then CT can feel like the same test being repeated because nobody trusts the last one. It is not — they answer three genuinely different questions, and each is better than the others at its own job.
Ultrasound asks what the ovarian mass looks like, and characterises the large majority confidently. MRI asks what tissue it is made of, and resolves the indeterminate minority — frequently preventing an operation done purely to find out. CT asks how far disease extends, covering the chest as well as the abdomen and pelvis, and largely determines whether surgery or chemotherapy comes first.
Not everyone needs all three. A woman whose ultrasound characterised her mass confidently as benign needs neither of the others. A woman with clearly advanced disease may go from ultrasound straight to CT without an MRI, because characterisation is no longer the question. If you are unsure why a particular scan was arranged, that is a fair and easily answered question. See MRI and transvaginal ultrasound.
First and most informative for the ovary itself. Characterises most masses confidently.
For the indeterminate minority. Frequently prevents a diagnostic operation.
Chest, abdomen and pelvis. Largely decides whether surgery or chemotherapy comes first.
A confidently benign ultrasound needs neither of the others. Ask why any particular scan was arranged.
Because CT is being used to stage the disease rather than to look at the ovary, and staging means establishing exactly how far it has reached. Ovarian cancer spreads primarily across the peritoneal surfaces within the abdomen, but it can cross above the diaphragm — as deposits on the diaphragm itself, as enlarged lymph nodes in the chest, or as fluid around the lung. Whether disease has crossed that boundary changes the stage, and the stage changes the treatment. A scan stopping at the diaphragm would leave that question unanswered.
Not well, and that is not what it is for. CT does not read tissue types the way MRI does, and it does not show the fine internal detail of a cyst the way transvaginal ultrasound does — so it characterises a small ovarian mass poorly. Its job is mapping the extent of disease, which it does very well. If the question you need answered is what a particular mass is made of, ultrasound comes first and MRI resolves the uncertain cases. Only pathological examination after removal gives a definitive tissue diagnosis.
Largely whether surgery comes first or chemotherapy does. In advanced ovarian cancer, outcomes are strongly linked to whether all visible disease can be removed at surgery. Where the CT suggests complete removal is achievable, primary surgery followed by chemotherapy is usually preferred. Where it suggests disease is too extensive to remove completely at the outset, chemotherapy is given first to shrink it, with surgery following — called neoadjuvant chemotherapy with interval debulking. Neither route is a lesser option; the evidence supports each in its own circumstances.
No, and this distinction matters a great deal. Extensive disease on CT means the treatment sequence changes, not that treatment is futile. Where complete surgical removal is not achievable at the outset, chemotherapy is given first to shrink the disease, with surgery following once it has responded. This is a well-established route with good evidence behind it, and ovarian cancer is frequently sensitive to platinum-based chemotherapy. Many women whose initial scan showed widespread disease respond substantially, and go on to have successful interval surgery.
It is a genuine consideration, which is why CT is not used casually or repeated without reason. A chest-abdomen-pelvis scan delivers considerably more radiation than a plain X-ray. In the context of staging a suspected or confirmed cancer, however, the information it provides substantially outweighs that risk — knowing the extent of disease is what determines the treatment plan. Where the question is characterising a mass rather than staging disease, MRI is preferred partly because it avoids radiation entirely, which is particularly relevant for younger women. CT is avoided in pregnancy.
Because CT cannot detect microscopic disease, and in ovarian cancer that matters enormously. Deposits too small to appear on any scan are frequently found in the samples taken during surgery — peritoneal washings, biopsies of the peritoneal surfaces, the omentum and lymph nodes — and those findings change the stage and therefore the treatment. So a CT showing no obvious spread is genuinely useful information but is not the same as confirming early disease. This is why proper systematic surgical staging matters and why an incompletely staged operation may need repeating.
The first consultation is free and runs to about 45 minutes — bring the CT report, since it usually explains why the treatment plan is what it is. Much of the useful work is going through what it actually found and why the plan follows from that. Chemotherapy and maintenance therapy, including neoadjuvant treatment before interval surgery, are delivered in-house at CION across more than 35 centres in Telangana and Andhra Pradesh. Debulking and staging surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there.